Measures of small-fiber neuropathy in HIV infection

Auton Neurosci. 2012 Jul 2;169(1):56-61. doi: 10.1016/j.autneu.2012.04.001. Epub 2012 Apr 28.

Abstract

Introduction: Noninvasive methods are needed to detect distal sensory polyneuropathy in HIV-infected persons on antiretroviral therapy (ART).

Methods: Quantitative sudomotor axon reflex test (QSART) and Utah Early Neuropathy Scale (UENS), small-fiber sensitive measures, were assessed in subjects with and without clinical neuropathy. Pain was assessed by visual analog scale (VAS).

Results: Twenty-two subjects had symptoms and signs of neuropathy, 19 had neither, and all were receiving ART. Median sweat volume (μL) was lower at all testing sites in those with neuropathy compared to those without (p<0.01 for all). UENS and VAS (mm) were higher in neuropathy subjects (p<0.05 for each). Lower sweat volume at all sites correlated with higher pin UENS subscore, total UENS, and VAS (p<0.05 for all). In multivariable analyses adjusting for age, CD4⁺ T cells, sex, and use of "d-drug" ART, QSART and UENS remained associated (p=0.003).

Conclusion: QSART and UENS have not been previously studied in this patient population and may identify small-fiber neuropathy in HIV-infected, ART-treated persons.

Publication types

  • Evaluation Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Anti-Retroviral Agents / adverse effects*
  • Anti-Retroviral Agents / therapeutic use
  • Axons / drug effects
  • Cohort Studies
  • Diagnostic Techniques, Neurological*
  • Early Diagnosis
  • Female
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / adverse effects
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Neurotoxicity Syndromes / diagnosis*
  • Neurotoxicity Syndromes / physiopathology
  • Pain Measurement
  • Peripheral Nervous System Diseases / etiology*
  • Polyneuropathies / etiology*
  • Prospective Studies
  • Reflex / drug effects
  • Reverse Transcriptase Inhibitors / adverse effects
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Sweating / drug effects

Substances

  • Anti-Retroviral Agents
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors